Denmark· DK-28106733022

Beyfortus

A nirsevimab product containing nirsevimab, registered in Denmark by Sanofi Winthrop Industrie. The same ATC class is registered in 14 of our 19 countries.

ATC J06BD08

Checked against Danish Medicines Agency (Denmark) on

Informational only — not a medical device.

SOURCE REGISTER · DKDanish Medicines Agency (Denmark)normalisedBeyfortusATCJ06BD08REGISTER NO.DK-28106733022PACKS LISTED1CHECKEDSeptember 30, 2026

Where it is registered

Nirsevimab is registered in 14 of 19 countries.

Countries holding a registration under ATC J06BD08 (nirsevimab), each read from that country’s own register.

  • This record: Denmark, from Danish Medicines Agency (Denmark)
  • 9 of them publish a price we can compare per daily dose

Nirsevimab · ATC J06BD08

14 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Icelandprice
  • Ireland
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

Danish Medicines Agency (Denmark)
Active substance
Nirsevimab
Manufacturer
Sanofi Winthrop Industrie
Country
Denmark (DK)
ATC code
J06BD08
ATC class
Nirsevimab
Reimbursed
Not published by this register
Source register
Danish Medicines Agency (Denmark)
Last checked
September 30, 2026

Packs & prices · 1

  • dk_varenummer
    28106733022

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Danish Medicines Agency (Denmark). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/b9240f46-1681-4b0d-a1e2-1e32101f67ca
GET /v1/drugs/b9240f46-1681-4b0d-a1e2-1e32101f67ca?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "injektionsvæske, opløsning i fyldt injektionssprøjte",
  "source": "dkma",
  "strength": "50 mg",
  "auth_role": "RAP",
  "dk_drugid": "28106733022",
  "substance": "Nirsevimab",
  "auth_procedure": "Central",
  "in_medicinpriser": true,
  "registration_date_serial": "44865"
}

See everything about nirsevimab.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.